US2017106040A1PendingUtilityA1

Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof

Assignee: NAT UNIV CHONBUK IND COOP FOUNDPriority: May 13, 2014Filed: Apr 8, 2015Published: Apr 20, 2017
Est. expiryMay 13, 2034(~7.8 yrs left)· nominal 20-yr term from priority
Inventors:Jong Kwan Park
A61K 36/8962A23L 33/105A23P 10/30A23L 33/30A23L 33/10A23P 10/40A23V 2002/00A23P 10/28A61K 36/746A23L 2/52A61K 36/43A61K 36/39A61P 15/08A61K 2236/333A61P 15/00
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition and health functional food for treating male infertility using a mixed herbal mixture. Through an in vitro sperm mobility promotion effect evaluation method experiment for investigating effects of an herbal extract of Morinda officinalis , Cuscuta seed, and/or Allium cepa of the present invention on changes in sperm count and mobility in human semen, it was verified that the composition increased sperm mobility. In addition, through an in vivo varicocele animal model evaluation method for investigating effects of the herbal extract on changes in sperm count and mobility in an in vivo varicocele animal model, it was verified that the composition samples of the present invention increased the sperm count in the semen obtained from spermiducts of a sample-administered group among varicocele-induced groups. Therefore, the herbal extract can be used in a pharmaceutical composition, health functional food, and health supplement food for treating male infertility.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition comprising a combination of extracts from  Morinda Officinalis  root,  Cuscuta  seed, and  Allium cepa  bulb as an active ingredient for treating male infertility. 
     
     
         2 . The pharmaceutical composition of  claim 1 , wherein the combination of extracts from  Morinda Officinalis  root,  Cuscuta  seed, and  Allium cepa  bulb has a range of mixed ratios based on the dried weight of each herb of 0.01-100:0.01-1:1-100 (w/w). 
     
     
         3 . The pharmaceutical composition of  claim 1 , wherein the male infertility is selected from the group consisting of an adverse response of an anti-cancer agent, azoospermia, oligospermia, asthenospermia, and teratospermia. 
     
     
         4 . A health functional food comprising a combination of extracts from  Morinda Officinalis  root,  Cuscuta  seed, and  Allium cepa  bulb as an active ingredient for the improvement of male infertility. 
     
     
         5 . The health functional food of  claim 4 , wherein the health food is selected from the group consisting of powder, granule, tablet, capsule, pill, suspension, emulsion, syrup, tea bag, leached tea, or beverage type. 
     
     
         6 . (canceled) 
     
     
         7 . A method of treatment of male infertility comprising administering the pharmaceutical composition of  claim 1  to a subject in need of treatment of male infertility. 
     
     
         8 . (canceled) 
     
     
         9 . The method of  claim 7 , further comprising the step of:
 obtaining extracts from  Morinda Officinalis  root,  Cuscuta  seed, and  Allium cepa  bulb;   mixing the extracts together to obtain the combination of extracts from  Morinda Officinalis  root,  Cuscuta  seed, and  Allium cepa  bulb; and   administering the combination of extracts to the subject in need of treatment of male infertility.   
     
     
         10 . The method of  claim 8 , wherein the combination of extracts from  Morinda Officinalis  root,  Cuscuta  seed, and  Allium cepa  bulb has a range of mixed ratios based on the dried weight of each herb of 0.01-100:0.01-1:1-100 (w/w). 
     
     
         11 . The method of  claim 7 , wherein the male infertility is selected from the group consisting of an adverse response of an anti-cancer agent, azoospermia, oligospermia, asthenospermia, and teratospermia. 
     
     
         12 . A method of manufacturing a medicament for the treatment of male infertility in a human or mammal comprising the steps of
 extracting a composition from  Morinda Officinalis  root,   extracting a composition from  Cuscuta  seed, and   extracting a composition from  Allium cepa  bulb; and   mixing the compositions together at mixed ratios ranging from 0.01-100:0.01-1:1-100, based on the dried weight of each composition (w/w).

Join the waitlist — get patent alerts

Track US2017106040A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.